Cite
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease
MLA
Robinson, Philip C.Terkeltaub, Robert Pillinger, Michael H.and Shah, Binita Karalis, Vangelis Karatza, Eleni Liew, David and Imazio, Massimo Cornel, Jan H.Thompson, Peter L.and Nidorf, Mark. Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..8b8e081fac0ff7bb038a2923434ff170&authtype=sso&custid=ns315887.
APA
Robinson, P. C. T. R. P. M. H. and S. B. K. V. K. E. L. D. and I. M. C. J. H. T. P. L. and N. M. (2022). Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease.
Chicago
Robinson, Philip C. Terkeltaub, Robert Pillinger, Michael H. and Shah, Binita Karalis, Vangelis Karatza, Eleni Liew, David and Imazio, Massimo Cornel, Jan H. Thompson, Peter L. and Nidorf, Mark. 2022. “Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..8b8e081fac0ff7bb038a2923434ff170&authtype=sso&custid=ns315887.